cropper

The Silver Surfer
Senior Citizens Surfing the Internet

  • Home
  • Categories
    • Health & Wellness
    • Money & Legal
    • Housing & Living
    • Lifestyle & Leisure
    • Technology for Seniors
    • Local Resources
December 10.2025
3 Minutes Read

Unlock Your Health: Discover the Connection Between Close Friends and Good Health

The Surprising Connection Between Close Friends and Good Health

The Role of Friendships in Promoting Long-Lasting Health

Friendship is more than just socializing; it's a powerful component of our overall well-being. Various studies have shown that maintaining close friendships can significantly enhance our physical and emotional health. In fact, research highlights how social isolation can be as damaging to health as smoking or obesity. According to Dr. Christopher Coe, Director at the Harlow Center for Biological Psychology, individuals who face loneliness are more prone to a multitude of health issues, including chronic diseases.

How Friends Boost Your Fitness Journey

If you're looking to increase your physical activity or start a new fitness routine, look no further than your friends. Collaborating with buddies in an exercise program can help keep you motivated and accountable. The Mayo Clinic emphasizes that those with friends are more likely to achieve their fitness goals than those who go at it alone. Exercising together can create a sense of camaraderie and make workouts more enjoyable.

The Hidden Health Risks of Isolation

The health implications of social isolation are grave. Recent findings published in the Journal of the American Heart Association indicate that social isolation raises the risk of heart disease and stroke by significant margins. Specifically, adults lacking strong social ties are at a 29% higher risk for heart disease. It underscores the importance of nurturing our social connections, especially as we age.

Friendship's Impact on Disease Management

When it comes to managing health conditions such as diabetes or heart disease, having a robust support network can make a world of a difference. Friends can assist in logistical tasks such as riding to doctor appointments or helping with meal preparations. A healthy support system has been shown to contribute positively to managing blood sugar levels in individuals with type 2 diabetes, thereby reinforcing the idea that friendships are important allies in health management.

The Longevity of Friendships

Beyond managing existing health conditions, friendships can even enhance longevity. Research indicates that quality social relationships can lower mortality risk at levels comparable to the effects of avoiding smoking or excessive drinking. Dr. Jamila Bookwala from Lafayette College points to data showing that those with supportive friendships enjoy longer, healthier lives.

Creating Stronger Connections

While many aspects of friendship can improve our health, the idea of making new friends can feel daunting, especially as adults. The science of friendship suggests various strategies to connect or reconnect with peers—often emphasizing the importance of shared experiences or simply reaching out. Engaging in social activities, attending community gatherings, or even striking conversations with acquaintances can offer substantial emotional rewards.

Final Thoughts on Friendships and Well-Being

Given the strong correlations between friendship, health, and longevity, it is vital to prioritize these connections in our lives. Most importantly, recognize that nurturing friendships is not just good for your heart but can significantly enhance your overall health. By investing in friendships, we’re not merely making memories; we are actively contributing to our well-being. Start today by reaching out to a friend—it's a step towards a healthier you.

Health & Wellness

16 Views

0 Comments

Write A Comment

*
*
Please complete the captcha to submit your comment.
Related Posts All Posts
11.19.2026

Breakthrough Insights: Diranersen Therapy Shows Benefits for Alzheimer's Patients Over Two Years

Update Understanding Tau Therapy's Promising Benefits for Alzheimer's Patients In a remarkable breakthrough for Alzheimer's research, diranersen, an investigational medication, continues to show significant benefits in slowing the decline of cognitive abilities. Recent findings from a two-year study confirm that this therapy works by targeting tau protein, a key factor in the progression of Alzheimer's disease. Presented at the Clinical Trials on Alzheimer's Disease (CTAD) conference, Dr. Lawren VandeVrede from the University of California San Francisco highlighted that over 96 weeks, diranersen led to a meaningful recovery in cognitive functions. How Diranersen Works and Its Impact on Cognitive Decline Diranersen is an antisense oligonucleotide therapy that aims to reduce tau levels, which can collect in the brain and contribute to the disease's progression. The results showed a 1.09-point improvement in the Clinical Dementia Rating-Sum of Boxes (CDR-SB) score among participants who received a 60-mg dose twice a year. This dosage displayed the most significant results, proving invaluable since a one-point change in CDR-SB is considered clinically meaningful. A Closer Look at the Study and Its Findings The CELIA trial enrolled 416 participants with mild cognitive impairment from Alzheimer's disease and tested different doses of diranersen. Interestingly, while various dosages were evaluated, the lower 60-mg dose performed the best, leading to a 38% improvement in cognitive measures between 76 and 96 weeks. As the findings continue to evolve, researchers are optimistic about this therapy's potential to enhance cognitive function for a longer duration, which could mean new hope for patients struggling with this debilitating disease. Safety and Future Implications of Diranersen While the results are promising, it is important to consider the safety profile. During the study, adverse events were common but mostly mild, such as headaches and post-lumbar puncture syndrome. These findings continuously reassure researchers about the therapy's tolerability. Experts emphasize that diranersen's ability to lower tau without affecting amyloid protein makes it particularly exciting. This presents a potential strategy in combined therapies that target multiple aspects of Alzheimer's, aiming for a more comprehensive approach to treatment. Looking Ahead: The Future of Alzheimer's Treatments The upcoming phase III trials will be crucial in confirming the effectiveness and safety of diranersen on a larger scale. As Laura Nisenbaum, interim chief science officer of the Alzheimer's Drug Discovery Foundation, points out, understanding how tau therapy can work alongside traditional anti-amyloid treatments could be groundbreaking in the fight against Alzheimer's disease. As Alzheimer's affects millions, continued research like this offers hope and insight into managing and potentially reversing symptoms. Stay informed about these developments as they may mark a new era in Alzheimer's treatment that could benefit not just today’s patients but future generations.

11.18.2026

Why High Cardiac Troponin I Readings Alone Aren't Enough

Update Understanding Cardiac Troponins: The Basics Cardiac troponins, particularly troponin I (cTnI), are essential blood markers that help doctors understand heart health. These proteins are released when the heart is damaged, and measuring their levels can help indicate the risk of cardiovascular problems. However, recent research warns that simply looking at cTnI levels might not give the whole picture. What Are Macrotroponins and Why Do They Matter? Macrotroponins are complex molecules formed from autoantibodies attaching to troponin. They are much larger than regular troponins and can linger in the bloodstream longer, making tests show heightened cTnI levels. In simple terms, while doctors often look at high cTnI levels to assess heart health, they must also consider if these high levels are due to macrotroponins. New Findings from Norway: A Wake-Up Call In a significant study from Norway involving over 3,700 community members, researchers discovered some surprising truths. Those with high cTnI readings and no macrotroponins faced a staggering 50% chance of developing cardiovascular problems over 8.3 years. In contrast, those with high cTnI but also possessing macrotroponins had a much lower incident rate of just 6.8%. Why Misclassifying Risks Can Be Dangerous This misclassification could lead to critical oversights in patient care. High cTnI readings can indicate severe risk, but if macrotroponins are present, the actual risk may be much lower. Thus, it’s imperative for physicians to consider both cTnI levels and the presence of macrotroponins to make informed medical decisions. The Need for Enhanced Diagnostic Practices The study emphasizes that by recognizing the influence of macrotroponins, healthcare providers can improve their assessments of cardiac risk. This means creating fresh guidelines that factor in both troponin levels and macrotroponin presence could be monumental in shaping more accurate health responses. Final Thoughts: What This Means for Patients For those monitoring heart health, these insights are crucial. Patients should be aware that high cTnI does not automatically signal danger, especially if macrotroponins are present. Engaging in discussions with healthcare providers about testing methods and what results actually indicate can empower patients to better understand their cardiovascular risks.

11.17.2026

The Hidden Dangers of Agent Orange: Linking Exposure to Parkinson's Disease

Update Understanding the Link Between Agent Orange and Parkinson’s Disease Recent research has unveiled significant findings regarding the health risks faced by Vietnam-era military veterans exposed to Agent Orange, a potent herbicide used during the Vietnam War. A study of over 4 million Veterans Affairs (VA) health records has established that these veterans are at a 57% higher risk of developing Parkinson's disease and other neurodegenerative disorders. This alarming statistic indicates that veterans were not just courageous soldiers but also faced long-term health consequences from their service. What Is Agent Orange? Agent Orange was a toxic herbicide extensively utilized by the U.S. military to clear vegetation and expose enemy positions. This chemical was not just an ordinary weedkiller; it was a mixture containing 2,4-dichlorophenoxyacetic acid (2,4-D) and 2,4,5-trichlorophenoxyacetic acid (2,4,5-T), along with TCDD, a highly toxic dioxin. Despite the phasing out of 2,4,5-T in the 1970s, the use of 2,4-D remains prevalent today across various sectors, including agriculture and landscaping, which raises critical public health questions. Health Impacts of Agent Orange on Veterans The study led by Dr. Gregory Scott and his team highlights that veterans who handled Agent Orange directly had even higher chances—up to twice as likely—of developing Parkinson’s disease and related conditions, including REM sleep behavior disorder. This reinforces the long-held suspicions of healthcare providers and the veterans themselves regarding the link between Agent Orange exposure and neurodegenerative diseases. Broader Implications Beyond Veterans Time and again, evidence suggests that the toxic effects of Agent Orange are not limited to veterans alone. People living near agricultural areas where 2,4-D is used—like farmers and groundskeepers—face similar risks. Notably, recent studies revealed that living close to golf courses is associated with a 126% increased risk of Parkinson's disease, illustrating how widespread this issue is beyond military circles. Why Does This Matter Now? As we continue to learn about the long-term consequences of Agent Orange exposure, it becomes increasingly clear that proactive measures should be taken to prevent future exposures to harmful herbicides and pesticides. Dr. Scott emphasizes the need for immediate action to comprehend and address the health risks associated with newer herbicides before they become entrenched in our understanding, just as Agent Orange was for veterans. Conclusion: A Call for Awareness The findings of this recent study are a wake-up call for not only veterans but for communities across the U.S. As the knowledge of dangerous chemicals continues to evolve, so too must our efforts to protect public health. Advocacy for research into environmental health effects and vigilant monitoring of agricultural chemicals are imperative to safeguard both current and future generations. Understanding these risks can lead to stronger policies protecting veterans and civilians alike.

Silver Surfer Media

A division of

Electronic Commerce Engineering Corporation

COMPANY

  • Privacy Policy
  • Terms of Use
  • Advertise
  • Contact Us
  • Menu 5
  • Menu 6

+19085200096

AVAILABLE FROM 9AM - 5PM

Monday ~ Friday

Green Township, New Jersey

 07860-5406

ABOUT US

The Sussex County Advisor is operated by synergetic.media a subsidiary of  Electronic Commerce Engineering Corporation, Green Township, NJ 07860-5406

© 2026 Electronic Commerce Engineering Corporation All Rights Reserved. 16 Wintermute Rd, Green Township, NJ 07860-5406 . Contact Us . Terms of Service . Privacy Policy

{"company":"Electronic Commerce Engineering Corporation","address":"16 Wintermute Rd","city":"Green Township","state":"NJ","zip":"07860-5406","email":"info@ecommerceengineering.com","tos":"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","privacy":"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"}

Terms of Service

Privacy Policy

Core Modal Title

Sorry, no results found

You Might Find These Articles Interesting

T
Please Check Your Email
We Will Be Following Up Shortly
*
*
*